These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 2363856)
1. Augmentation of the effect of doxorubicin with low-dose tumor necrosis factor in experimental liver metastasis. Bloom ND; Norbergs DA; Sherman B; Sadjadi M; Ramaswamy G; Jacobs R; Ackerman N Mol Biother; 1990 Jun; 2(2):121-4. PubMed ID: 2363856 [TBL] [Abstract][Full Text] [Related]
2. Augmentation of antitumor efficacy by the combination of recombinant tumor necrosis factor and chemotherapeutic agents in vivo. Krosnick JA; Mulé JJ; McIntosh JK; Rosenberg SA Cancer Res; 1989 Jul; 49(14):3729-33. PubMed ID: 2736513 [TBL] [Abstract][Full Text] [Related]
3. Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat. Kooistra KL; Rodriguez M; Powis G Cancer Res; 1989 Feb; 49(4):977-82. PubMed ID: 2912564 [TBL] [Abstract][Full Text] [Related]
4. Effect of low-dose tumor necrosis factor-alpha in combination with STEALTH liposomal cisplatin (SPI-077) on soft-tissue- and osteosarcoma-bearing rats. Hoving S; van Tiel ST; Eggermont AM; ten Hagen TL Anticancer Res; 2005; 25(2A):743-50. PubMed ID: 15868905 [TBL] [Abstract][Full Text] [Related]
5. Combination cytokine immunotherapy with tumor necrosis factor alpha, interleukin 2, and alpha-interferon and its synergistic antitumor effects in mice. McIntosh JK; Mulé JJ; Krosnick JA; Rosenberg SA Cancer Res; 1989 Mar; 49(6):1408-14. PubMed ID: 2784349 [TBL] [Abstract][Full Text] [Related]
6. Topical chemotherapy of intradermal Walker 256 carcinosarcoma with diaziquone and doxorubicin in the rat. Moore DJ; Powis G; Richardson RL; Pittelkow MR Cancer Res; 1985 Nov; 45(11 Pt 1):5466-72. PubMed ID: 4053022 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of tumor blood flow and tumoricidal effect of doxorubicin by intraportal epinephrine in experimental liver metastasis. Bloom ND; Kroop E; Sadjadi M; Jacobs R; Ramaswamy G; Ackerman NB Arch Surg; 1987 Nov; 122(11):1269-72. PubMed ID: 3675191 [TBL] [Abstract][Full Text] [Related]
8. [Intra-arterial infusion chemotherapy combine with noradrenalin administration (an improved antitumor effect using a cancerous blood vessel]. Sato T; Katsumi S; Murai T; Kawaguchi T Gan To Kagaku Ryoho; 1985 Oct; 12(10):1915-21. PubMed ID: 3931558 [TBL] [Abstract][Full Text] [Related]
9. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo. Singh TR; Shankar S; Chen X; Asim M; Srivastava RK Cancer Res; 2003 Sep; 63(17):5390-400. PubMed ID: 14500373 [TBL] [Abstract][Full Text] [Related]
10. Enhanced therapeutic effect against liver W256 carcinosarcoma with temperature-sensitive liposomal adriamycin administered into the hepatic artery. Zou Y; Yamagishi M; Horikoshi I; Ueno M; Gu X; Perez-Soler R Cancer Res; 1993 Jul; 53(13):3046-51. PubMed ID: 8319211 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms by which chemotherapeutic agents augment the antitumor effects of tumor necrosis factor: involvement of the pattern shift of cytokines from Th2 to Th1 in tumor lesions. Inagawa H; Nishizawa T; Honda T; Nakamoto T; Takagi K; Soma G Anticancer Res; 1998; 18(5D):3957-64. PubMed ID: 9854510 [TBL] [Abstract][Full Text] [Related]
12. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. Keane MM; Ettenberg SA; Nau MM; Russell EK; Lipkowitz S Cancer Res; 1999 Feb; 59(3):734-41. PubMed ID: 9973225 [TBL] [Abstract][Full Text] [Related]
13. Target distribution of magnetic albumin nanoparticles containing adriamycin in transplanted rat liver cancer model. Gong LS; Zhang YD; Liu S Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):365-8. PubMed ID: 15313670 [TBL] [Abstract][Full Text] [Related]
14. [Influences of tumor necrosis factor-alpha on protein metabolism and cell-cycle kinetics in malignant tumor]. Ye SL; Tang ZY; Bistrian BR Zhonghua Zhong Liu Za Zhi; 1994 Sep; 16(5):349-52. PubMed ID: 7895585 [TBL] [Abstract][Full Text] [Related]
15. Synergistic antitumor effects of immunotherapy with recombinant interleukin-2 and recombinant tumor necrosis factor-alpha. McIntosh JK; Mulé JJ; Merino MJ; Rosenberg SA Cancer Res; 1988 Jul; 48(14):4011-7. PubMed ID: 3260130 [TBL] [Abstract][Full Text] [Related]
16. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system. Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416 [TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of recombinant human tumor necrosis factor in combination with hyperthermia, chemotherapy, or immunotherapy. Haranaka K; Sakurai A; Satomi N J Biol Response Mod; 1987 Aug; 6(4):379-91. PubMed ID: 3625230 [TBL] [Abstract][Full Text] [Related]
18. [Cytotoxicity of recombinant human tumor necrosis factor (rHTNF) alone and in combination with chemotherapeutic agents on human ovarian cancer cells]. Zhao EF Zhonghua Fu Chan Ke Za Zhi; 1993 Mar; 28(3):153-6, 188. PubMed ID: 8354095 [TBL] [Abstract][Full Text] [Related]
19. Protection of multiple antioxidants Chinese herbal medicine on the oxidative stress induced by adriamycin chemotherapy. Qin XJ; He W; Hai CX; Liang X; Liu R J Appl Toxicol; 2008 Apr; 28(3):271-82. PubMed ID: 17582587 [TBL] [Abstract][Full Text] [Related]
20. Antitumor effect of recombinant human tumor necrosis factor-alpha analog combined with desmuramyl dipeptides LK-409 or LK-410 on sarcoma in mice. Sersa G; Novakovic S; Stalc A Mol Biother; 1992 Dec; 4(4):188-92. PubMed ID: 1476673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]